These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 20308863)

  • 1. Factors affecting graft and patient survival after live donor kidney transplantation in the UK.
    Fuggle SV; Allen JE; Johnson RJ; Collett D; Mason PD; Dudley C; Rudge CJ; Bradley JA; Watson CJ;
    Transplantation; 2010 Mar; 89(6):694-701. PubMed ID: 20308863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
    Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
    Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well-Matched Deceased Donor Transplants.
    Opelz G; Döhler B; Middleton D; Süsal C;
    Transplantation; 2017 Nov; 101(11):2789-2792. PubMed ID: 28471872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
    Freitas MC
    Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Kidney Graft Survival Calculator that Accounts for Mismatches in Age, Sex, HLA, and Body Size.
    Ashby VB; Leichtman AB; Rees MA; Song PX; Bray M; Wang W; Kalbfleisch JD
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1148-1160. PubMed ID: 28596416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-recipient age difference and graft survival in living donor kidney transplantation.
    Lee YJ; Chang JH; Choi HN; Jung JY; Kim YS; Chung WK; Park YH; Lee HH
    Transplant Proc; 2012 Jan; 44(1):270-2. PubMed ID: 22310630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
    Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
    Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
    Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
    Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What has changed in more than 40 years of activity and 3000 kidney transplants at Policlinico University Hospital, Milan.
    Berardinelli L; Raiteri M; Beretta C; Pasciucco A; Giussani A; Carini M; Marenghi C; Rossetti A; Piccolo G
    Clin Transpl; 2011; ():99-110. PubMed ID: 22755406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight years of outcomes of the Dutch Living Donor Kidney Exchange Program.
    de Klerk M; Kal-van Gestel JA; Haase-Kromwijk BJ; Claas FH; Weimar W;
    Clin Transpl; 2011; ():287-90. PubMed ID: 22755421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidneys From Deceased Elderly Donors: Factors Associated With Adverse Outcomes.
    Adekoya AO; Halawa A
    Exp Clin Transplant; 2016 Feb; 14(1):32-7. PubMed ID: 26862822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of amino acid mismatch in the UNOS dataset.
    Sasaki N; El-Awar N; Idica A
    Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes.
    Øien CM; Reisaeter AV; Leivestad T; Dekker FW; Line PD; Os I
    Transplantation; 2007 Mar; 83(5):600-6. PubMed ID: 17353781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2002; ():1-20. PubMed ID: 12971433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidneys from older living donors provide excellent intermediate-term outcomes after transplantation.
    Balachandran VP; Aull MJ; Charlton M; Afaneh C; Serur D; Leeser DB; Del Pizzo J; Kapur S
    Transplantation; 2012 Sep; 94(5):499-505. PubMed ID: 22892992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney transplantation using expanded criteria donors in Korea.
    Jeong JC; Kim MG; Ro H; Kim YJ; Park HC; Kwon HY; Jeon HJ; Ha J; Ahn C; Yang J
    Transplant Proc; 2012 Jan; 44(1):54-6. PubMed ID: 22310577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and outcomes of delayed graft function after living-donor kidney transplantation.
    Redfield RR; Scalea JR; Zens TJ; Muth B; Kaufman DB; Djamali A; Astor BC; Mohamed M
    Transpl Int; 2016 Jan; 29(1):81-7. PubMed ID: 26432507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
    Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
    Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.